Compartmentalized regulation of macrophage arachidonic acid metabolism by unknown
Brief Definitive Report 
COMPARTMENTALIZED  REGULATION  OF  MACROPHAGE 
ARACHIDONIC  ACID  METABOLISM 
BY  A.  O. S.  FELS**,  N. A.  PAWLOWSKI*,  E.  L. ABRAHAM*,  AND 
Z. A. COHN* 
From the *Department  of Cellular Physiology and Immunology,  The Rockefeller University, 
New York 10021; and the ~Department of Pulmonary Disease, The New York Hospital-Cornell 
University Medical Center, New York 10021 
Mouse  peritoneal  macrophages  given  a  phagocytic  stimulus  release  large 
amounts  of cyclooxygenase and  lipoxygenase metabolites  of arachidonic  acid 
(20:4) (1,2). After macrophage activation through intraperitoneal administration 
of inflammatory agents, stimulated 20:4 metabolism by peritoneal macrophages 
is quantitatively and qualitatively altered (3, 4). 
To determine whether downregulation of 20:4 metabolism occurs in macro- 
phage populations outside a local inflammatory site, we have developed a method 
for  injection  of particulates  into  adjacent  anatomic  compartments  containing 
comparable populations of mononuclear phagocytes. For this purpose we have 
used the resident macrophage populations that exist in the pleural and peritoneal 
cavities.  Our  results indicate  that  the  downregulation  of 20:4  metabolism  can 
occur as a localized process involving a contained macrophage population. 
Materials and Methods 
Anatomic Separation  of the Pleural and Peritoneal Cavities.  25-30 gm female ICR mice 
(Trudeau Institute, Saranac Lake, NY) were given intrapleural (i.pl.) or i.p. injections of 
0.2 ml of 2% Evans Blue Dye (Sigma Chemical Co., St. Louis, MO) in isotonic PBS lacking 
calcium and magnesium (PD). Dissection of the animals revealed local retention of dye in 
these anatomic compartments. 
Culture of Macrophages.  Peritoneal cells were harvested as previously described (5). 
Pleural cells (6) were obtained after harvest of peritoneal cells, after bleeding from the 
inferior vena cava. Each pleural cavity was lavaged twice with 1 ml of sterile PD. Pleural 
and peritoneal macrophages were then cultured in a-MEM (Gibco, Grand Island,  NY) 
containing 10% FCS as adherent cells (3). 
Activated  Macrophage  Populations.  Activated macrophage populations were obtained 
at 14 d, unless otherwise noted, after either i.p. or i.pl.  injection of mice with 1.4 mg of 
formalin-killed Corynebacterium parvum (Coparvax, Burroughs Wellcome, Co., Research 
Triangle Park, NC). Resident peritoneal and pleural cells were harvested simultaneously 
from noninjected mice. 
Synthesis of 20:4 Oxygenated Metabolites.  Macrophage cultures maintained in c~-MEM 
and 10% FCS were labeled for 16 h with 0.5/~Ci of 5,6,8,9,11,12,14,15-[~H]20:4 (82-91 
Ci/mmol, sp act; New England Nuclear, Boston, MA).  After three washes,  the cultures 
were overlaid with a-MEM (no serum) and 320 ~g of zymosan in a 35-mm dish was used 
as  phagocytic stimulus.  Media  were  removed after  incubation  at  37°C  for  90  rain. 
Determination of radiolabel release into the medium and medium extraction were done 
as previously described (3). Cell protein was determined by the method of Lowry (7). 
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Separation of~H-labeled Metabolites of HPLC.  [~H]20:4  metabolites extracted from the 
media samples were separated and identified using two HPLC systems. In the first system, 
a column (4.6 × 250 ram) of 5 #m Ukraspbere ODS (Altex Scientific, Inc., Berkeley, CA) 
was eluted isocratically at a flow rate of 1 ml/min with (a) 60 ml of methanol/water/acetic 
acid (65:35:0.1,  vol/vol/vol,  adjusted to pH 5.4 with NH4OH), (b) 40 ml of methanol/ 
water/acetic acid  (75:25:0.01,  vol/vol/vol),  and  (c)  40  ml  of  methanol/acetic acid 
(100:0.01,  vol/vol). In some experiments the second solvent was omitted. The column 
effluent was monitored for UV absorbance at 280 nm. The radiolabel content of each 
fraction was determined. A second HPLC system (8) was used for separation  of cyclo- 
oxygenase products.  Products were identified by comparison  of retention times  with 
authentic ~H-labeled standards. 
Extraction and Separation of Cellular Lipids.  For the analysis of [SH]20:4 incorporated 
into cellular lipids, extracts of labeled macrophage cultures were subjected to TLC (9). 
Gas-liquid chromatography (GLC) analysis of fatty acid  methyl esters  separated from 
macrophage phospholipids was performed as previously described (9). 
Results 
In this study we have looked at  the macrophage populations  of two serous 
cavities  separated  by  the  diaphragm.  These  populations  could  be  stimulated 
independently by local injections of C. parvum, In each case this lead to a rapid 
influx of polymorphonuclear leukocytes (PMNs) into the injected, but not the 
adjacent, noninjected cavity. The number of PMNs peaked at day 7, but was still 
significantly elevated at day 14.  After the injection of the inflammatory agent 
we compared the 20:4 metabolism in these two macrophage populations. 
Phospholipid Fatty Acid Composition and [3H]20:4  Uptake.  The phospholipid 
fatty acid compositions (20:4 was 25  mol-% of the total phospholipid fatty acid 
content) and phospholipid phosphorus contents (205 _+  10 pmol lipid inorganic 
phosphate  [Pi]/ug cell  protein) of the resident pleural  and  peritoneal  macro- 
phages were similar. After labeling of the cells with [~H]20:4 for 16 b, uptake of 
the radiolabel was >85% and esterification into phospholipid was >85%. Similar 
uptake and distribution of label into individual phospholipid species was found 
for inflammatory pleural and peritoneal macrophages. 
20:4 Metabolism by Resident Macrophages.  After incubation for 90 rain with a 
maximum phagocytic stimulus (zymosan), release of radiolabel  by the pleural 
and peritoneal macrophages was comparable. HPLC analysis of medium extracts 
showed that >95% of the [3H]20:4 released into the medium by each population 
was oxygenated metabolites. Both pleural and peritoneal cells released predom- 
inantly cyclooxygenase products, 72 and 81%  of the total  metabolites, respec- 
tively (Table I, a and b).  Leukotriene C (LTC) was also a significant metabolite. 
Interestingly,  LTC  production  by  the  pleural  macrophages  was  consistantly 
higher than by peritoneal macrophages (17 +  5 vs.  12 +  3% of the total). The 
calculated (10) molar quantities of LTC secreted by resident pleural and perito- 
neal  macrophages  were  3.9  +  0.13  and  2.8  +-  0.84  pmol/~g  cell  protein. 
Integrated UV absorbance measurements of LTC purified by HPLC (Fig.  1), 
after correction for recoveries (50-60%), were in agreement (>80%) with these 
calculated values. 
Resident peritoneal macrophages synthesize the cyclooxygenase  products pros- 
tacyclin (recovered as its stable  metabolite, 6-keto-PGF~) and PGE2 in  nearly 
equal proportions (3). Resident pleural cells release similar cyclooxygenase prod- 
ucts,  as  shown  in  Table  I,  a  and  b.  For  either  resident  macrophage  type, 
thromboxane (recovered as the stable metabolite TXB2) was <3% of the cyclo- 754  FELS  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  I 
Zymosan-induced 20:4 Metabolism by Macrophages  from Injected and Noninjected Cavities vs. 
Resident Cells 
Immunization route  Percent [SH] 
and macrophage  20:4 released 
population 
Percent of total metabolites released 
Cyclooxygenase  Lipoxygenase 
6°keto  Mono- 
PGF~.  TXB~  PGF~o  PGE~  HHT  LTC  Hetes 
None 
a  PL  24±6  29±5  2±1  2±2  39±5  2±2  17±5  3±2 
b  PE  21±3  40±6  1±1  2±2  38±4  2±1  12±3  1±1 
lntrapleural 
c  PL  4±2  8±2  17±5  3±2  49±4  4±1  4±3  8±5 
d  PE  25±4  41±4  1±1  2±1  33±7  2±2  13±5  2±1 
Intraperitoneal 
e  PL  10±4  16±3  5±1  3±1  56±3  4±3  5±4  6±1 
f  PE  5±2  7±2  21±3  1±1  56±8  5±2  4±4  5±3 
Macrophages isolated from the pleural (PL) or peritoneal (PE) cavities of animals previously injected with C. parvum, 
as described in Materials and Methods, or noninjected controls were labeled overnight with {SH]20:4, washed, and 
then challenged with an optimal phagocytic dose of zymosan particles. After 90  rain, the percentage of cellular 
radiolabel content released into medium was determined (3). 20:4 metabolites were extracted from the medium 
and analyzed by HPLC (3). >98% of the extracted label represented oxygenated metabolites in each case, except 
for cells isolated from locally injected cavities (c and  f) (83-86%).  Individual products are expressed as a percentage 
of the total oxygenated metabolites. Most of the unidentified products (5-11% of the total) eluted as polar material 
at the solvent front, All results are expressed as the mean ±SD of four experiments. The radiolabel contents of 
purified metabolites were used for quantitation (Table I1) by the method of Scott et al (3). HHT,  12-bydroxyhep- 
tadecatrienoic acid; Mono-Hete, monohydroxyeicosatetraenoic acid. 
oxygenase metabolites. 
Macrophages from  the Inflamed  Serous  Cavity.  As shown in  Table  I,  c and f, 
both the pleural  macrophages  after i.pl. and the peritoneal  macrophages  after 
i.p. injections showed a >75%  reduction in the amount of [3H]20:4 released in 
response to maximum phagocytic stimulus.  Small increases in the levels of free 
or unmetabolized  20:4  were found (_<14% of total radiolabel  released  in each 
case). LTC synthesis decreased by >75% (pleural) and >67% (peritoneal) (Table 
I, c and f).  As shown in Fig.  1,  the amounts of LTC detectable during HPLC 
elutions were significantly reduced to <190 pmol/mg  cell protein.  Both locally 
activated populations also showed alterations in proportions of cyclooxygenase 
metabolites, with 6-keto-PGF~ decreased 65-70%, and thromboxane increased 
2-5-fold  (Table  I,  c and f).  The  molar  quantities  of thromboxane  produced, 
however,  were  approximately  equivalent  to  those  produced  by  the  resident 
populations (Table II).  These alterations in macrophage  20:4 metabolism  were 
present at 4, 7, and  14 d following the injection of C. parvum. 
Macrophages  Harvested from  Noninjected  Cavities.  Although  pleural  macro- 
phages  from  animals  injected  i.pl.  showed  maximal  downregulation  of  20:4 
metabolism,  no downregulation  could be  demonstrated  in the peritoneal  cells 
harvested  from  the same  mice.  Both  the release  and  spectrum  of metabolites 
produced  by  these  cells  were  comparable  to  those  seen  in  the  resident  cells 
(Tables I d and II d). As shown in Fig.  1, molar quantities of LTC were at the 
level  of resident cells from uninjected animals.  In contrast to this,  the pleural 
macrophages harvested from mice injected i.p. showed partial reduction in 20:4 
release  (Table  I  e).  The  percentages  of  6-keto-PGFl~,  PGE2,  and  TXB2 FELS  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  II 






Amount produced (pmol/mg cell protein) 
6-keto PGF~o  TXB~  PGE~  LTC  HHT 
Nolle 
a  PL  6,745 -+ 1,734  421 -+ 236  10,921  -+ 703  3,946 4- 1,302  917 4- 131 
b  PE  9,327 -+ 1,242  260 -+ 237  9,436 -+ 2,767  2,800--+ 898  376 -+ 148 
lntrapleural 
c  PL  382-+370  158-+38  947-+507  189-+65  232-+254 
d  PE  11,098 4- 3,348  209 -+ 184  10,956 -+ 2,601  4,237 -+ 678  707 -+ 308 
lntraperitone~l 
e  PL  1,340 -+ 747  487 -+ 272  5,447 -+ 3,107  260 -+ 69  349 -+ 307 
f  PE  184-+116  369-+43  1,333_.+499  157-+21  160-+152 
Purification and quantification o(metabolites produced were 9erformed as described in the legend to Table I. 
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FIGURE  1.  HPLC profiles of 20:4 oxygenated metabolites released by resident pleural (A) 
and peritoneal (B) macrophages as well as pleural (C) and peritoneal (D) macrophages from 
i.pl.-injected  mice after a  90-rain exposure to  320  pg of zymosan. Media  from  each  set of 
cultures were pooled, extracted, and chromatographed as described in Materials and Methods. 
UV absorbance at 280 nm was measured simultaneously. The original macrophage cultures 
for A-D contained  148,  323,  1,329,  and  901  pg  of protein,  respectively.  In  this system, 
cyclooxygenase products eluted at  10-18 rain,  LTC at 20-25 rain, and HHT  at 56-64 rain. 
Mono-Hetes and u nreacted arachidonate eluted at 85-105 rain and 110-120 rain, respectively, 
in the 140-rain chromatograph, and at 70-80 rain and 80-100 in the  100-fraction chronmto- 
graphs. Synthesis of LTB, -D, or -E was not detected under any of these conditions. 756  FELS  ET  AL.  BRIEF  DEFINITIVE  REPORT 
showed a partial shift toward the pattern seen in maximally downregulated cells. 
(Table I, a, c, and e). However, LTC production by these cells (5%) was similar 
to that by pleural macrophages after local injection (4%). Individual metabolite 
production by each macrophage population is summarized in Table II. 
Discussion 
In this study the availability of two adjacent but anatomically distinct macro- 
phage populations  has allowed us to examine whether the downregulation of 
20:4  metabolism  seen  following  i.p.  challenge  with  C.  parvum  occurs  as  a 
generalized phenomenon or is a localized event. The changes in 20:4 metabolism 
found in pleural but not peritoneal macrophages harvested from i.pl.-injected 
animals indicate that downregulation can be a  completely localized event not 
mediated solely  by  a  systemic  factor.  Although  maximal  downregulation  in 
pleural cells was seen as early as 4 d after i.pl. injection and persisted for >14 d, 
the peritoneal macropbages'  20:4  metabolism remained unaffected at all time 
points. 
An intermediate reduction of 20:4 release and a partial modulation of cycloox- 
ygenase products can also occur, as seen in the pleural macrophages following 
i.p. injection. LTC production in these cells was maximally decreased, suggesting 
that the lipoxygenase pathway is a more sensitive indicator of this process. 
The way in which the i.p. injections affected the partial downregulation of the 
pleural macrophages is not known. When radioactive C. parvum is injected i.p., 
a  small percentage of the radioactivity can be recovered from the lungs (12), 
suggesting that antigenic spread to the pleural space may have been responsible 
for the changes in 20:4 metabolism we observed. Labeled C. parvum injected i.v. 
gives  an  identical  distribution  of  radioactivity  (11)  but  does  not  cause  any 
alterations in the 20:4 metabolism of pleural cells (our unpublished observations). 
Alternatively, mononuclear cells sensitized to the antigen may themselves have 
migrated to the thorax via the bloodstream or the lymphatics. 
To  date,  the  factors  mediating  downregulation  have  not  been  identified. 
Release of cyclooxygenase products by mouse peritoneal macrophages has been 
shown to correlate closely with the cell's state of activation (3), and it has therefore 
been proposed that the capacity for 20:4 metabolism is a function of macrophage 
activation.  Crude  lymphokine preparations,  however, that  cause  macrophage 
activation  in  vitro  by  gross  morphologic,  surface  antigen,  and  microbicidal 
criteria do not cause downregulations (3). Recently IFN-3,,  a T  cell product, has 
been shown to be the specific lymphokine responsible for macrophage activation 
as  defined by  H202  production  and  microbicidal  activity  (1);  however,  only 
modest alterations of 20:4  metabolism are seen  in  macrophages treated with 
IFN-3  ~ in vitro (A. Aderem, personal communication). Finally, 20:4 metabolism 
remains depressed in  macrophages long after they have lost  the microbicidal 
capacity of the activated state (3). 
Therefore,  it  is  likely  that  additional  inflammatory  mediators  or  cell-cell 
interactions are involved. It is possible,  for example, that PMNs and/or PMN 
products play a central role in this process, since large numbers of this cell type 
were present  in  the  injected cavity each time  downregulation was  observed. FELS ET  AL.  BRIEF  DEFINITIVE  REPORT  757 
Whatever their cell of origin, the factors that regulate the flux of 20:4 metabolism 
in macrophages appear to be contained within the local environment. 
Summary 
We  show  that  downregulation  of arachidonic acid  (20:4)  metabolism  which 
occurs  following  i.p.  injection  of C.  parvum  can  occur  in  a  single,  localized 
macrophage  population,  and  is  therefore unlikely  to  be  mediated  solely by a 
systemic factor. 
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Note added in proof" Recent studies (C. S. Tripp, K. M. Leahy, and P. Needleman. 1985. 
J. Clin. Invest.  76:898) of 20:4 metabolism by resident and activated peritoneal macro- 
phages are in agreement with the data in Table II (b and f) and previous studies (3). 
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